skip to the content

B-cell lymphoblastic lymphoma

Lymphoblastic lymphomas (LLs) are rare tumours accounting for approximately 2% of all NHLs (The Non-Hodgkin's Lymphoma Classification Project 1997). Less than 20% of LLs are of B-cell lineage and these tumours are generally seen in elderly patients, often after transformation of a previously undiagnosed small cell lymphoma. They most commonly present like leukaemia, with infiltration of the bone marrow, blood and CNS.

B-cell LLs comprise lymphoblasts, which are slightly larger than small lymphocytes and have a B-cell phenotype (CD19+, CD79+, sIg+). The immunoglobulin heavy chain gene is usually rearranged; rearrangement of the light chain gene is also seen in some cases1.

B-cell lymphoblastic lymphoma

References

  1. Sweetenham J, & Borowiz M. In: Non-Hodgkin's lymphomas. Mauch P, Armitage J, Coiffier B, Dalla-Favera R, Harris N, ed. Lippincott Williams & Wilkins 2004:503-13.

Print

 

Your feedback is valuable to MabThera

Tell a friend

Share your knowledge with your colleagues

Recommend this website

Prognostic factors

Prognostic factors provide a method of assessing the likely course of a disease and help drive treatment decisions.

Learn more

Safety

Safety

MabThera has more than 10 years of clinical experience and more than 1,000,000 patients have been treated to date.

Find out more

MabThera product characteristics

MabThera product characteristics

Find out more about the characteristics of MabThera and how it is used in the treatment of non-Hodgkin's lymphoma.

Read more